Within a month of Suzanne Shema's arrival at Onyx Pharmaceuticals as its first general counsel, the company plunged into the acquisition that remains its only buy to date. She managed the negotiation while getting up to speed on her new workplace.
Work hasn't slowed down for Shema since.
Embroiled in a lawsuit against business partner Bayer Healthcare Pharmaceuticals Inc., she helped manage two teams of lawyers, one working on the litigation and another ... (continued)
May 13, 2012
Suzanne M. Shema
Executive Vice President, General Counsel, and Corporate Secretary for Onyx Pharmaceuticals Inc.
Read more about Suzanne M. Shema...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Already a subscriber?
Sign In